Phase II study of neoadjuvant gemcitabine, epirubicin, and albumin-bound nab paclitaxel (GEA) in locally advanced breast cancer with SPARC tumor assessments

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 603-603 ◽  
Author(s):  
D. A. Yardley ◽  
R. C. Inhorn ◽  
D. Daniel ◽  
B. Daniel ◽  
Y. Naot ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Locally Advanced Breast Cancer ◽  
Locally Advanced ◽  
Advanced Breast

Epirubicin and Docetaxel as Neoadjuvant Treatment of Locally Advanced Breast Cancer: A Phase II Study

2010 ◽  
Vol 96 (2) ◽  
pp. 229-233 ◽  
Author(s):  
Davide Lombardi ◽  
Simona Scalone ◽  
Diana Crivellari ◽  
Maria Donatella Magri ◽  
Nicoletta La Mura ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Locally Advanced Breast Cancer ◽  
Locally Advanced ◽  
Neoadjuvant Treatment ◽  
Advanced Breast

A Phase II Study of Docetaxel, Doxorubicin, and Infusional 5-Fluorouracil in the Treatment of Patients With Locally Advanced Breast Cancer

2006 ◽  
Vol 29 (5) ◽  
pp. 484-489 ◽  
Author(s):  
Lata Chandi Thatai ◽  
Priya Vishnubhotla ◽  
Laura Biernat ◽  
Lawrence Flaherty ◽  
Patricia LoRusso ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Locally Advanced Breast Cancer ◽  
Locally Advanced ◽  
Advanced Breast
Sign in / Sign up

Export Citation Format

Share Document